Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,761,532
-$5,156 QoQ
Shares Held
598,528
+30.2% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. URGN ranks #135 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in URGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,761,532 | 598,528 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,766,688 | 459,722 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $8,477,073 | 424,916 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,980,904 | 290,577 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,144,733 | 284,334 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $3,381,608 | 317,522 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $4,012,653 | 315,957 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,423,308 | 263,606 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,707,930 | 113,862 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,713,315 | 114,221 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $751,594 | 53,647 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $324,814 | 31,383 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $651,928 | 70,555 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $208,223 | 23,475 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $196,285 | 23,592 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $313,144 | 38,235 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $433,147 | 49,730 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $513,281 | 53,973 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $961,766 | 57,180 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $1,054,102 | 69,031 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,014,212 | 103,399 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,158,761 | 175,292 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,078,413 | 159,586 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,742,081 | 143,265 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,132,539 | 119,537 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||